FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1Dmitri Pchejetski, Olivier Cuvillier, Torsten Böhler et al.|Cancer Research|2010Cited by 146
Pharmacodynamics of Single Doses of the Novel Immunosuppressant FTY720 in Stable Renal Transplant PatientsKlemens Budde, Hans‐Hellmut Neumayer, Robert Schmouder et al.|American Journal of Transplantation|2003Cited by 103
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancerQi Wang, Dmitri Pchejetski, Heba Alshaker et al.|Scientific Reports|2017Cited by 82
Therapeutic Potential of Targeting SK1 in Human CancersHeba Alshaker, Dmitri Pchejetski, Silvia Ottaviani et al.|Advances in cancer research|2013Cited by 56
Therapeutic potential of targeting sphingosine kinase 1 in prostate cancerDmitri Pchejetski, Jonathan Waxman, Torsten Böhler et al.|Nature Reviews Urology|2011Cited by 49